Salud
STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal study
STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal study
ENIn English
A Tenax Therapeutics drug designed to treat a type of heart failure associated with high blood pressure in the lungs failed in a closely watched study.
STAT News1 min de lecturaOriginal en EN
A Tenax Therapeutics drug designed to treat a type of heart failure associated with high blood pressure in the lungs failed in a closely watched study.
Leer artículo completo en STAT News
